Nom du produit:N-{5-methyl-5H,6H,7H-pyrrolo[1,2-b][1,2,4]triazol-7-ylidene}hydroxylamine

IUPAC Name:N-{5-methyl-5H,6H,7H-pyrrolo[1,2-b][1,2,4]triazol-7-ylidene}hydroxylamine

CAS:2138805-49-7
Formule moléculaire:C6H8N4O
Pureté:95%+
Numéro de catalogue:CM433511
Poids moléculaire:152.16

Unité d'emballage Stock disponible Prix($) Quantité
CM433511-250mg 3-4 Weeks ǕſDz
CM433511-500mg 3-4 Weeks ȷDzȌ
CM433511-1g 4-5 Weeks ȌƋȦ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:2138805-49-7
Formule moléculaire:C6H8N4O
Point de fusion:-
Code SMILES:CC1CC(=NO)C2=NC=NN12
Densité:
Numéro de catalogue:CM433511
Poids moléculaire:152.16
Point d'ébullition:
N° Mdl:MFCD30613312
Stockage:

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.